Results 21 to 30 of about 28,587 (260)

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND β2-AGONIST OF INDACATEROL: PROSPECTS OF COBD THERAPY

open access: yesМедицинский совет, 2016
The therapy by fixed combinations, LABA/LAACD on the basis of indacaterol and glycopyrronium bromide is characterized by a high clinical efficacy compared to monocomponents of the product, tiotropium, and a fixed combination of LABA/iCGS.
S. N. AVDEEV
doaj   +1 more source

Β2-agonist in patients with chronic obstructive pulmonary disease

open access: yesМедицинский совет, 2014
The pathogenesis of chronic obstructive pulmonary disease (COPD) is explained by chronic inflammation leading to bronchial obstruction. The mechanism of COPD determines the key role of bronchodilators in the basic therapy of the disease, among which β2 ...
N. N. Mescheryakova
doaj   +1 more source

COPD: maximization of bronchodilation [PDF]

open access: yesMultidisciplinary Respiratory Medicine, 2014
The most recent guidelines define COPD in a multidimensional way, nevertheless the diagnosis is still linked to the limitation of airflow, usually measured by the reduction in the FEV1/FVC ratio below 70%. However, the severity of obstruction is not directly correlated to symptoms or to invalidity determined by COPD.
Stefano Nardini   +9 more
openaire   +6 more sources

Recent trends in management of bronchial asthma

open access: yesZagazig Journal of Pharmaceutical Sciences, 2021
Bronchial Asthma is the most common chronic inflammatory disease of lungs. The prevalence of asthma is increasing worldwide, and the disease possesses a substantial global health and economic burden.
Ashraf elsayed Sileem   +3 more
doaj   +1 more source

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2014
Background and objectives: Metered-dose inhalers plus spacers (MDI-spacer) are as effective as, or better than, nebulizers in aerosol delivery. The selection of aerosol delivery system for hospitalized children can have a significant impact on the ...
S.A. Alhaider, H.A. Alshehri, K. Al-Eid
doaj   +1 more source

Bronchodilators use in patients with COPD

open access: yes, 2017
Background: Bronchodilators are commonly used as maintenance and rescue therapy in patients with COPD. We aimed to examine the prescribing patterns of bronchodilators in clinical practice.
Dong, Yaa-Hui;Hsu, Chia-Lin;Li, Ying-Ying;Chang, Chia-Hsuin;Lai, Mei-Shu   +1 more
core   +1 more source

Experience of using double bronchodilation therapy in patients with COPD

open access: yesМедицинский совет, 2021
Chronic obstructive pulmonary disease (COPD) is currently one of the most socially significant diseases that leads to a significant decrease in the daily activity and productivity of patients, as well as their rapid invalidization.
I. V. Demko   +4 more
doaj   +1 more source

Prescribing patterns of nebulized bronchodilators: A prospective chart review

open access: yes, 2016
Dear Editor, Bronchodilator misuse is widespread in the medical profession. The correct therapeutic use of bronchodilators is important both for hospital and primary care physicians.
Yaxley, Julian P, Julian P Yaxley
core   +1 more source

Newer therapeutic options in chronic obstructive pulmonary disease

open access: yesJournal of Advanced Lung Health, 2023
Chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), are the third leading cause of death worldwide behind only cardiovascular deaths (ischemic heart disease and stroke) and cancers.
Jesin Kumar Chakkamadathil
doaj   +1 more source

Clinical experience of using double bronchodilation therapy in patients with COPD

open access: yesМедицинский совет, 2019
Chronic obstructive pulmonary disease is today one of the socially significant diseases, and its treatment remains a major medical problem.Currently, the main goals of treating patients with COPD are: eliminating symptoms and improving the quality of ...
I. V. Demko   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy